Sommaire

• • ·Table of Contents

    Page :i

    
• • ·Editorial Board

    Page :v

    
• • ·Information for Readers

    Page :vi

    

• Editorials

  • ·Prognostication on the spot! The evolving importance of urinary creatinine in heart failure

    Page :186-188

    Meredith A. Brisco-Bacik

    

• Trial Designs

  • ·A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the “DAPT-STEMI trial”

    Page :11-17

    Elvin Kedhi, Enrico Fabris, Martin van der Ent, Mark W. Kennedy, Pawel Buszman, Clemens von Birgelen, Stéphane Cook, Hans Wedel, Felix Zijlstra

    Résumé Résumé Plan Plan   
  • ·Lisinopril or Coreg CR in reducing cardiotoxicity in women with breast cancer receiving trastuzumab: A rationale and design of a randomized clinical trial

    Page :87-92

    Maya Guglin, Pamela Munster, Angelina Fink, Jeffrey Krischer

    Résumé Résumé Plan Plan  
  • ·Rationale, design, and baseline characteristics of the Salt Substitute and Stroke Study (SSaSS)—A large-scale cluster randomized controlled trial

    Page :109-117

    Bruce Neal, Maoyi Tian, Nicole Li, Paul Elliott, Lijing L. Yan, Darwin R. Labarthe, Liping Huang, Xuejun Yin, Zhixin Hao, Sandrine Stepien, Jingpu Shi, Xiangxian Feng, Jianxin Zhang, Yuhong Zhang, Ruijuan Zhang, Yangfeng Wu

    Résumé Résumé Plan Plan  
  • ·A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure—Trial design of the REDUCE FMR study

    Page :167-174

    Steven L. Goldberg, Ian Meredith, Thomas Marwick, Brian A. Haluska, Janusz Lipiecki, Tomasz Siminiak, Nawzer Mehta, David M. Kaye, Horst Sievert, for the REDUCE FMR Investigators

    Résumé Résumé Plan Plan  
  • ·Bridging Income Generation with Group Integrated Care for cardiovascular risk reduction: Rationale and design of the BIGPIC study

    Page :175-185

    Rajesh Vedanthan, Jemima H. Kamano, Hana Lee, Benjamin Andama, Gerald S. Bloomfield, Allison K. DeLong, David Edelman, Eric A. Finkelstein, Joseph W. Hogan, Carol R. Horowitz, Simon Manyara, Diana Menya, Violet Naanyu, Sonak D. Pastakia, Thomas W. Valente, Cleophas C. Wanyonyi, Valentin Fuster

    Résumé Résumé Plan Plan   

• Clinical Investigations

  • ·Feasibility of exercise stress echocardiography and myocardial response in patients with repaired congenital heart disease

    Page :1-10

    Babar S. Hasan, Fatima I. Lunze, Najveen Alvi, Keri M. Shafer, Jonathan Rhodes

    Résumé Résumé Plan Plan   
  • ·Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1-year outcomes: A patient-level analysis of randomized clinical trials

    Page :18-25

    Harry P. Selker, James E. Udelson, Robin Ruthazer, Ralph B. D'Agostino, Melissa Nichols, Ori Ben-Yehuda, Ingo Eitel, Christopher B. Granger, Paul Jenkins, Akiko Maehara, Manesh R. Patel, E. Magnus Ohman, Holger Thiele, Gregg W. Stone

    Résumé Résumé Plan Plan  
  • ·Does perceived stress increase the risk of atrial fibrillation? A population-based cohort study in Denmark

    Page :26-34

    Simon Graff, Anders Prior, Morten Fenger-Grøn, Bo Christensen, Charlotte Glümer, Finn Breinholt Larsen, Mogens Vestergaard

    Résumé Résumé Plan Plan  
  • ·The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF

    Page :35-41

    Ulrik M. Mogensen, Lars Køber, Søren L. Kristensen, Pardeep S. Jhund, Jianjian Gong, Martin P. Lefkowitz, Adel R. Rizkala, Jean L. Rouleau, Victor C. Shi, Karl Swedberg, Michael R. Zile, Scott D. Solomon, Milton Packer, John J.V. McMurray, PARADIGM-HF Investigators and Committees 1

    Résumé Résumé Plan Plan   
  • ·Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation

    Page :42-52

    David J. Goldberg, Victor Zak, Bryan H. Goldstein, Shan Chen, Michelle S. Hamstra, Elizabeth A. Radojewski, Eileen Maunsell, Seema Mital, Shaji C. Menon, Kurt R. Schumacher, R. Mark Payne, Mario Stylianou, Jonathan R. Kaltman, Tina M. deVries, James L. Yeager, Stephen M. Paridon, Pediatric Heart Network Investigators

    Résumé Résumé Plan Plan  
  • ·A laboratory association between hemoglobin and VerifyNow P2Y12 reaction unit: A systematic review and meta-analysis

    Page :53-64

    Yun Gi Kim, Jung-Won Suh, Dirk Sibbing, Adnan Kastrati, Young-Guk Ko, Yangsoo Jang, Young-Seok Cho, Tae-Jin Youn, In-Ho Chae, Dong-Ju Choi, Hyo-Soo Kim

    Résumé Résumé Plan Plan   
  • ·Digital health intervention during cardiac rehabilitation: A randomized controlled trial

    Page :65-72

    R. Jay Widmer, Thomas G. Allison, Ryan Lennon, Francisco Lopez-Jimenez, Lilach O. Lerman, Amir Lerman

    Résumé Résumé Plan Plan  
  • ·Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study

    Page :73-81

    Usman Baber, Samantha Sartori, Melissa Aquino, Annapoorna Kini, Samir Kapadia, Sandra Weiss, Craig Strauss, J. Brent Muhlestein, Catalin Toma, Sunil V. Rao, Anthony DeFranco, Kanhaiya L. Poddar, Jaya Chandrasekhar, William Weintraub, Timothy D. Henry, Sameer Bansilal, Brian A. Baker, Elizabeth Marrett, Stuart Keller, Mark Effron, Stuart Pocock, Roxana Mehran

    Résumé Résumé Plan Plan   
  • ·Electronically self-assessed functional capacity and exercise testing: A comparison of the Duke Activity Status Index and Patient-Reported Outcomes Measurement Information System tools

    Page :82-86

    Ryan A. Coute, Jesse M. Ehrenfeld, Deepak K. Gupta, Maxim A. Terekhov, Jonathan P. Wanderer

    Résumé Résumé Plan Plan  
  • ·Atrial fibrillation incrementally increases dementia risk across all CHADS₂ and CHA₂DS₂VASc strata in patients receiving long-term warfarin

    Page :93-98

    Kevin G. Graves, Heidi T. May, Victoria Jacobs, Tami L. Bair, Scott M. Stevens, Scott C. Woller, Brian G. Crandall, Michael J. Cutler, John D. Day, Charles Mallender, Jeffrey S. Osborn, J. Peter Weiss, T. Jared Bunch

    Résumé Résumé Plan Plan   
  • ·True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: A meta-analysis

    Page :99-108

    Davor Vukadinovi?, Daniel Lavall, Aleksandra Nikolovska Vukadinovi?, Bertram Pitt, Stefan Wagenpfeil, Michael Böhm

    Résumé Résumé Plan Plan   
  • ·Clinical SYNTAX score predicts outcomes of patients undergoing coronary artery bypass grafting

    Page :118-126

    Giovanni Melina, Emiliano Angeloni, Simone Refice, Francesco Monti, Roberto Serdoz, Stefano Rosato, Fulvia Seccareccia, Furio Colivicchi, Roberta Serdoz, Francesco Paneni, Riccardo Sinatra

    Résumé Résumé Plan Plan  
  • ·Characterization of hemodynamically stable acute heart failure patients requiring a critical care unit admission: Derivation, validation, and refinement of a risk score

    Page :127-135

    Ismail R. Raslan, Paul Brown, Cynthia M. Westerhout, Justin A. Ezekowitz, Adrian F. Hernandez, Randall C. Starling, Christopher O'Connor, Finlay A. McAlister, Brian H. Rowe, Paul W. Armstrong, Sean van Diepen

    Résumé Résumé Plan Plan   
  • ·Diastolic dysfunction revisited: A new, feasible, and unambiguous echocardiographic classification predicts major cardiovascular events

    Page :136-146

    Niklas Dyrby Johansen, Tor Biering-Sørensen, Jan Skov Jensen, Rasmus Mogelvang

    Résumé Résumé Plan Plan  
  • ·Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial

    Page :147-155

    Freddy Abnousi, Vandana Sundaram, Celina M. Yong, Jayne Prats, Efthymios N. Deliargyris, Gregg W. Stone, Christian W. Hamm, Philippe Gabriel Steg, Charles Michael Gibson, Harvey D. White, Matthew J. Price, Philippe Généreux, Manisha Desai, Lingyao Yang, Victoria Y. Ding, Robert A. Harrington, Deepak L. Bhatt, Kenneth W. Mahaffey

    Résumé Résumé Plan Plan  
  • ·Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization

    Page :156-166

    Anthony J. Dalby, Shmuel Gottlieb, Derek D. Cyr, Erik Magnus Ohman, Darren K. McGuire, Witold Ruzyllo, Deepak L. Bhatt, Stephen D. Wiviott, Kenneth J. Winters, Keith A.A. Fox, Paul W. Armstrong, Harvey D. White, Dorairaj Prabhakaran, Matthew T. Roe, for the TRILOGY ACS Investigators

    Résumé Résumé Plan Plan   
  • ·Clinical and prognostic value of spot urinary creatinine in chronic heart failure—An analysis from GISSI-HF

    Page :189-195

    Jozine M. ter Maaten, Aldo Pietro Maggioni, Roberto Latini, Serge Masson, Gianni Tognoni, Luigi Tavazzi, Stefano Signorini, Adriaan A. Voors, Kevin Damman

    Résumé Résumé Plan Plan   

• Corrigendum

  • ·Corrigendum to ‘Association of Standard Clinical and Laboratory Variables with Red Blood Cell Distribution Width (RDW)’[Am. Heart J. (2016) 22–28]

    Page :196

    Patrícia O. Guimarães, Jie-Lena Sun, Kristian Kragholm, Svati H. Shah, Karen S. Pieper, William E. Kraus, Elizabeth R. Hauser, Christopher B. Granger, L. Kristin Newby, for the MURDOCK Horizon 1 Cardiovascular Study Investigators Durham, NC